VYGR
VYGR
NASDAQ · Biotechnology

Voyager Therapeutics Inc

$3.96
-0.17 (-4.12%)
As of Mar 29, 10:34 PM ET ·
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 17 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +1,072.7% upside
Low Target $29.94
Average Target $46.44
High Target $64.67
Current Price $3.96
Current
$3.96
Target
$46.44
$29.94 $46.44 avg $64.67
Scenario Analysis
Bear Case
$29.94
656.1%
Low target
Base Case
$46.44
+1,072.7%
Avg target
Bull Case
$64.67
+1,533.1%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$5.55
-28.6% from high
52-Week Low
$2.65
+49.7% from low
Target vs 52W High
$46.44
+736.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.9%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +157.7%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.5%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.0%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.5%